# Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

> **NCT07031674** · — · COMPLETED · sponsor: **Yipeng Liu** · enrollment: 56 (actual)

## Conditions studied

- Lupus Nephritis
- Belimumab

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07031674
- **Lead sponsor:** Yipeng Liu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07031674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07031674, "Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07031674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*